U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07176338) titled 'Role of Metformin in Posterior Capsule Opacification' on Sept. 08.
Brief Summary: Determination of concentrations of systemically applied metformin in human lens capsule and its ability to lower the proliferation rate of human lens epithelial cells in vitro.
Study Start Date: Oct. 12, 2022
Study Type: INTERVENTIONAL
Condition:
Cataract
Diabetes Mellitus Type 2
Intervention:
DIAGNOSTIC_TEST: Blood and lens capsule samples for PK testing
Blood samples and lens capsule tissue will be collected from patients for PK testing
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Vienna Institute for Research in Ocular Surgery
Infor...